C-Phycocyanin attenuates cisplatin-induced nephrotoxicity in mice

Renal Failure

Volumn 35, Issue 7, 2013, Pages 1054-1055

  Nasri, Hamid ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cisplatin; Gender; Nephrotoxicity

Indexed keywords

C PHYCOCYANIN; CISPLATIN; PHYCOCYANIN; UNCLASSIFIED DRUG;

LETTER; NEPHROTOXICITY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; SEX DIFFERENCE;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; KIDNEY DISEASES; MALE; PHYCOCYANIN;

EID: 84880309465     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.810158     Document Type: Letter

References (14)

1. Lim BJ, Jeong JY, Chang YK, et al. C-phycocyanin attenuates cisplatin-induced nephrotoxicity in mice. Ren Fail. 2012; 34(7):892-900.
2. Pezeshki Z, Nematbakhsh M, Mazaheri S, et al. Estrogen abolishes protective effect of erythropoietin against cisplatin-induced nephrotoxicity in ovariectomized rats. ISRN Oncol. 2012;2012:890310. DOI:10.5402/2012/890310.
3. Eshraghi-Jazi F, Nematbakhsh M, Nasri H, et al. The protective role of endogenous nitric oxide donor (L-arginine) in cisplatin-induced nephrotoxicity: gender related differences in rat model. J Res Med Sci. 2011;16(11):1389-1396.
4. Haghighi M, Nematbakhsh M, Talebi A, et al. The role of angiotensin II receptor 1 (AT1) blockade in cisplatin-induced nephrotoxicity in rats: gender-related differences. Ren Fail. 2012; 34(8):1046-1051.
5. Ghorbani A, Omidvar B, Parsi A. Protective effect of selenium on cisplatin induced nephrotoxicity: a double-blind controlled randomized clinical trial. J Nephropathology. 2013;2(2):129-134. DOI:10.5812/nephropathol.10656
6. Nematbakhsh M, Ashrafi F, Pezeshki Z, et al. A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: which one is the first observation as side effect of cisplatin-induced toxicity in animal model. J Nephropathol. 2012;1(3):190-193. DOI: 10.5812/nephropathol.8122.
7. Solati M, Mahboobi HR. Paraoxonase enzyme activity and dyslipidemia in chronic kidney disease patients. J Nephropathology. 2012;1(3):123-125. DOI: 10.5812/nephropathol.8106.
8. Kam-Tao Li PK, Burdmann EA, Mehta RL. Acute kidney injury: global health alert. J Nephropathol. 2013;2(2):90-97. DOI: 10.5812/nephropathol.10449
9. Rafieian-Kopaei M, Nasri H, Nematbakhsh M, et al. Erythropoietin ameliorates gentamicin-induced renal toxicity: a biochemical and histopathological study. J Nephropathol. 2012;1(2):109-116.
10. Nematbakhsh M, Pezeshki Z, Eshraghi-Jazi F, et al. Vitamin E, vitamin C, or losartan is not nephroprotectant against Cisplatininduced nephrotoxicity in presence of estrogen in ovariectomized rat model. Int J Nephrol. 2012;2012:284896.
11. Gheissari A, Hemmatzadeh S, Merrikhi A, Fadaei Tehrani S, Madihi Y. Chronic kidney disease in children: a report from a tertiary care center over 11 years. J Nephropathol. 2012; 1(3):177-182. DOI: 10.5812/nephropathol.8119.
12. Kari J. Epidemiology of chronic kidney disease in children. J Nephropathol. 2012;1(3):162-163. DOI: 10.5812/nephropathol.8113.
13. Gheissari A, Mehrasa P, Merrikhi A, Madihi Y. Acute kidney injury: a pediatric experience over 10 years at a tertiary care center. J Nephropathol. 2012;1(2):101-108. DOI: 10.5812/nephropathol.7534.
14. Nematbakhsh M, Talebi A, Nasri H, et al. Some evidence for sex-based differences in cisplatin-induced nephrotoxicity in rats. Clin Exp Med Lett. 2012;53(1-229):31 pages.